Cancer, Ovarian Completed Phase 2 Trials for DB09290 (Ramosetron)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01012336Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/CarboplatinTreatment